| Conserved role of intragenic DNA methylation in regulating alternative promoters AK Maunakea, RP Nagarajan, M Bilenky, TJ Ballinger, C D’Souza, ... Nature 466 (7303), 253-257, 2010 | 1972 | 2010 |
| DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation K Martinowich, D Hattori, H Wu, S Fouse, F He, Y Hu, G Fan, YE Sun Science 302 (5646), 890-893, 2003 | 1673 | 2003 |
| Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma BE Johnson, T Mazor, C Hong, M Barnes, K Aihara, CY McLean, ... Science 343 (6167), 189-193, 2014 | 1431 | 2014 |
| Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications RA Harris, T Wang, C Coarfa, RP Nagarajan, C Hong, SL Downey, ... Nature biotechnology 28 (10), 1097-1105, 2010 | 767 | 2010 |
| VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex KV Lu, JP Chang, CA Parachoniak, MM Pandika, MK Aghi, D Meyronet, ... Cancer cell 22 (1), 21-35, 2012 | 600 | 2012 |
| The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer RJA Bell, HT Rube, A Kreig, A Mancini, SD Fouse, RP Nagarajan, S Choi, ... Science 348 (6238), 1036-1039, 2015 | 572 | 2015 |
| Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation SD Fouse, Y Shen, M Pellegrini, S Cole, A Meissner, L Van Neste, ... Cell stem cell 2 (2), 160-169, 2008 | 524 | 2008 |
| DNA methylation controls the timing of astrogliogenesis through regulation of JAK-STAT signaling G Fan, K Martinowich, MH Chin, F He, SD Fouse, L Hutnick, D Hattori, ... Oxford University Press for The Company of Biologists Limited 132 (15), 3345 …, 2005 | 486 | 2005 |
| Epigenetic regulation of neural gene expression and neuronal function J Feng, S Fouse, G Fan Pediatric research 61 (7), 58-63, 2007 | 339 | 2007 |
| X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations Y Shen, Y Matsuno, SD Fouse, N Rao, S Root, R Xu, M Pellegrini, ... Proceedings of the National Academy of Sciences 105 (12), 4709-4714, 2008 | 246 | 2008 |
| Genome-scale DNA methylation analysis SD Fouse, RP Nagarajan, JF Costello Epigenomics 2 (1), 105-117, 2010 | 179 | 2010 |
| Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment HF van Thuijl, T Mazor, BE Johnson, SD Fouse, K Aihara, C Hong, ... Acta neuropathologica 129, 597-607, 2015 | 178 | 2015 |
| Connective tissue growth factor inhibition enhances cardiac repair and limits fibrosis after myocardial infarction LE Vainio, Z Szabó, R Lin, J Ulvila, R Yrjölä, T Alakoski, J Piuhola, ... JACC: Basic to Translational Science 4 (1), 83-94, 2019 | 66 | 2019 |
| Recurrent epimutations activate gene body promoters in primary glioblastoma RP Nagarajan, B Zhang, RJA Bell, BE Johnson, AB Olshen, V Sundaram, ... Genome research 24 (5), 761-774, 2014 | 51 | 2014 |
| Response of primary glioblastoma cells to therapy is patient specific and independent of cancer stem cell phenotype SD Fouse, JL Nakamura, CD James, S Chang, JF Costello Neuro-oncology 16 (3), 361-371, 2014 | 42 | 2014 |
| DNA fragmentation simulation method (FSM) and fragment size matching improve aCGH performance of FFPE tissues JM Craig, N Vena, S Ramkissoon, A Idbaih, SD Fouse, M Ozek, A Sav, ... PloS one 7 (6), e38881, 2012 | 35 | 2012 |
| Na+/K+-ATPase β2-subunit (AMOG) expression abrogates invasion of glioblastoma-derived brain tumor-initiating cells MZ Sun, JM Kim, MC Oh, M Safaee, G Kaur, AJ Clark, O Bloch, ME Ivan, ... Neuro-oncology 15 (11), 1518-1531, 2013 | 34 | 2013 |
| Epigenetics of neurological cancers SD Fouse, JF Costello Future oncology 5 (10), 1615-1629, 2009 | 31 | 2009 |
| Cancer stem cells activate STAT3 the EZ way SD Fouse, JF Costello Cancer cell 23 (6), 711-713, 2013 | 29 | 2013 |
| Methods for cancer epigenome analysis RP Nagarajan, SD Fouse, RJA Bell, JF Costello Epigenetic Alterations in Oncogenesis, 313-338, 2013 | 24 | 2013 |
Yin Shen, Ph.D.Associate Professor, University of California, San Francisco在 ucsf.edu 的电子邮件经过验证
Yin Shen, Ph.D.Associate Professor, University of California, San Francisco在 ucsf.edu 的电子邮件经过验证